Philip Bischoff

2.2k total citations · 1 hit paper
60 papers, 1.4k citations indexed

About

Philip Bischoff is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Philip Bischoff has authored 60 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 13 papers in Oncology and 9 papers in Surgery. Recurrent topics in Philip Bischoff's work include Cell death mechanisms and regulation (6 papers), Single-cell and spatial transcriptomics (5 papers) and Cholesterol and Lipid Metabolism (5 papers). Philip Bischoff is often cited by papers focused on Cell death mechanisms and regulation (6 papers), Single-cell and spatial transcriptomics (5 papers) and Cholesterol and Lipid Metabolism (5 papers). Philip Bischoff collaborates with scholars based in France, Germany and Belgium. Philip Bischoff's co-authors include Karine Aupeix, B. Hugel, Holger Lill, Thierry Martin, J.‐L. Pasquali, David Horst, J M Freyssinet, Bang Luu, Marielle Christ and José Enrique Mejía and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Philip Bischoff

55 papers receiving 1.4k citations

Hit Papers

Causes of death and comorbidities in hospitalized patient... 2021 2026 2022 2024 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Bischoff France 17 590 361 209 187 174 60 1.4k
Stacy S. Shord United States 28 714 1.2× 1.0k 2.9× 274 1.3× 272 1.5× 133 0.8× 69 2.7k
Ting Liang China 20 384 0.7× 167 0.5× 107 0.5× 98 0.5× 166 1.0× 122 1.4k
Nana Wang China 18 284 0.5× 352 1.0× 136 0.7× 163 0.9× 156 0.9× 49 1.1k
Chengshui Chen China 22 734 1.2× 168 0.5× 157 0.8× 142 0.8× 177 1.0× 92 1.5k
Maki Hasegawa Japan 27 701 1.2× 622 1.7× 125 0.6× 126 0.7× 90 0.5× 68 2.2k
Maria Timofeeva United Kingdom 24 797 1.4× 347 1.0× 177 0.8× 46 0.2× 221 1.3× 67 2.0k
Ulf Tidefelt Sweden 25 1.2k 2.1× 989 2.7× 116 0.6× 135 0.7× 111 0.6× 63 2.6k
Ping Wei China 18 491 0.8× 232 0.6× 61 0.3× 136 0.7× 92 0.5× 56 1.3k
Vasileios Ragos Greece 19 403 0.7× 233 0.6× 80 0.4× 103 0.6× 90 0.5× 98 1.1k
Angela Ogden United States 24 1.5k 2.5× 575 1.6× 99 0.5× 87 0.5× 51 0.3× 52 2.3k

Countries citing papers authored by Philip Bischoff

Since Specialization
Citations

This map shows the geographic impact of Philip Bischoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Bischoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Bischoff more than expected).

Fields of papers citing papers by Philip Bischoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Bischoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Bischoff. The network helps show where Philip Bischoff may publish in the future.

Co-authorship network of co-authors of Philip Bischoff

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Bischoff. A scholar is included among the top collaborators of Philip Bischoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Bischoff. Philip Bischoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rüscher, Martina, Joonbaek Jang, Andrea Martini, et al.. (2025). Laboratory‐Based Time‐Resolved In Situ X‐Ray Absorption Spectroscopy for Tracking Transformations of Working Electrocatalysts. Chemistry - Methods. 5(10).
2.
Blanc, Eric, Stefan Peidli, Philip Bischoff, et al.. (2024). High‐confidence calling of normal epithelial cells allows identification of a novel stem‐like cell state in the colorectal cancer microenvironment. International Journal of Cancer. 155(9). 1655–1669. 1 indexed citations
3.
Addante, Annalisa, Sara Timm, Petra Schrade, et al.. (2024). Ileal mucus viscoelastic properties differ in Crohn’s disease. Mucosal Immunology. 17(4). 713–722. 4 indexed citations
4.
Bischoff, Philip, et al.. (2024). GPA33 expression in colorectal cancer can be induced by WNT inhibition and targeted by cellular therapy. Oncogene. 44(1). 30–41. 3 indexed citations
5.
Hoffmann, Inga, Mihnea P. Dragomir, Paul Jank, et al.. (2023). LRP1B—a prognostic marker in tubo-ovarian high-grade serous carcinoma. Human Pathology. 141. 158–168. 1 indexed citations
6.
Hoffmann, Inga, Mihnea P. Dragomir, Catarina Alisa Kunze, et al.. (2023). Increased expression of IDO1 is associated with improved survival and increased number of TILs in patients with high-grade serous ovarian cancer. Neoplasia. 44. 100934–100934. 5 indexed citations
7.
Bischoff, Philip, Michael Bockmayr, David Horst, et al.. (2023). Single-cell gene regulatory network prediction by explainable AI. Nucleic Acids Research. 51(4). e20–e20. 24 indexed citations
9.
Jank, Paul, Jonas Leichsenring, Inga Hoffmann, et al.. (2023). High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma. Journal of Ovarian Research. 16(1). 150–150. 5 indexed citations
10.
Ihlow, Jana, Inga Hoffmann, Philip Bischoff, et al.. (2022). Low Expression of RGS2 Promotes Poor Prognosis in High-Grade Serous Ovarian Cancer. Cancers. 14(19). 4620–4620. 8 indexed citations
11.
Bischoff, Philip, Alexandra Trinks, Benedikt Obermayer, et al.. (2022). The single‐cell transcriptional landscape of lung carcinoid tumors. International Journal of Cancer. 150(12). 2058–2071. 18 indexed citations
12.
Bischoff, Philip, Alexandra Trinks, Benedikt Obermayer, et al.. (2021). Single-cell RNA sequencing reveals distinct tumor microenvironmental patterns in lung adenocarcinoma. Oncogene. 40(50). 6748–6758. 131 indexed citations
13.
Özdirik, Burcin, Henning Jann, Philip Bischoff, et al.. (2021). PD-L1 – inhibitors in neuroendocrine neoplasia. Medicine. 100(1). e23835–e23835. 10 indexed citations
14.
Arnold, Alexander, Christine Sers, Aysel Ahadova, et al.. (2020). The majority of β-catenin mutations in colorectal cancer is homozygous. BMC Cancer. 20(1). 1038–1038. 28 indexed citations
15.
Arndt, Jörg, Denise Treue, Philip Bischoff, et al.. (2020). Novel methods for in vitro modeling of pancreatic cancer reveal important aspects for successful primary cell culture. BMC Cancer. 20(1). 417–417. 17 indexed citations
16.
Coelho, David, Barbara Fischer, Vincent Holl, et al.. (2002). Induction of apoptosis by high linear energy transfer radiation: role of p53. Canadian Journal of Physiology and Pharmacology. 80(7). 644–649. 14 indexed citations
17.
Coelho, David, Vincent Holl, D Weltin, et al.. (2000). Caspase-3-like activity determines the type of cell death following ionizing radiation in MOLT-4 human leukaemia cells. British Journal of Cancer. 83(5). 642–649. 38 indexed citations
18.
Holl, Vincent, David Coelho, D Weltin, et al.. (2000). Ex VivoDetermination of the Effect of Whole-Body Exposure to Fast Neutrons on Murine Spleen Cell Viability and Apoptosis. Radiation Research. 154(3). 301–306. 8 indexed citations
19.
Gény, Bernard, François Piquard, P Haberey, et al.. (1997). Safety of a new transpulmonary echocontrast agent (albunex®) in repeated echocardiographic studies in patients. Clinical Cardiology. 20(2). 111–115. 12 indexed citations
20.
Weltin, D, V. Picard, Karine Aupeix, et al.. (1995). Immunosuppressive activities of 6(5h)-phenanthridinone, a new poly(adp-ribose)polymerase inhibitor. International Journal of Immunopharmacology. 17(4). 265–271. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026